Showing 401 - 420 results of 99,140 for search '(( 5 w decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.44s Refine Results
  1. 401
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413

    TNFα significantly decreases PRLR immunoreactivity in the outer root sheath of hair follicles. by Ewan A. Langan (405804)

    Published 2013
    “…<p>(A) PRLR IR in the outer root sheath of control hair follicles (black arrows) was reduced in comparison PRLR IR after treatment with TNFα at concentrations of (B) 0.5 ng/ml and (C) 5 ng/ml. …”
  14. 414
  15. 415

    Increased CDK13 complexes expression decreases PNC prevalence. by Yasmine Even (1888192)

    Published 2016
    “…SiRNA2 only faintly diminished CDK13 expression levels and did not significantly altered PNC prevalence. In contrast, siRNA5 strongly altered CDK13 expression, leading to a significant decrease in PNC prevalence. …”
  16. 416
  17. 417
  18. 418
  19. 419

    Processive receptor methylation compromises adaptation and decreases signaling noise. by William Pontius (460803)

    Published 2013
    “…(C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i><sub>0</sub>. …”
  20. 420

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”